FDA approves combination therapy for blurry vision
The FDA has approved Yuvezzi (carbachol and brimonidine tartrate), a once-daily eye drop to treat presbyopia in adults. Presbyopia is...
approves
FDA approves $2.59 million gene therapy for SMA
The FDA has approved Itvisma (onasemnogene abeparvovec-brve) to treat children two years and older, teens, and adults living with spinal...
Thalassaemia gene therapy: NICE approves Nobel Prize-winning CRISPR technology for NHS use
Hundreds of NHS England (NHSE) patients are set to benefit from access to the first gene therapy in Europe for...
UK medicines regulator approves world-first gene-editing treatment for blood disorders
UK medicines regulator approves world-first gene-editing treatment for blood disorders The UK has...
FDA approves two gene therapies for sickle cell, bringing hope to thousands with the disease
CNN — The US Food and Drug Administration approved two gene-based treatments for sickle cell disease Friday, including the first...
US approves two gene therapies for sickle cell disease
This electron microscope image provided by the National Institutes of Health in 2016 shows a blood cell altered by sickle...
UK approves world-first gene-editing treatment for blood disorders | Imperial News
The UK has become the first country in the world to approve a gene therapy as a potential cure for...
